Filters

BAG3 Antibody, Biotin Conjugated

BAG3 Antibody, Biotin Conjugated size: 0.1ml 333

Price 333
Size 0.1ml
Long name Biotin Conjugated, BAG3 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationBiotinylated
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenBAG3
SpecificityThis is a highly specific antibody against BAG3
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from human BAG3
Gene ID number9531
Tested applications IHC-P, WB
Recommended dilutions IHC-P(1:100-500), WB(1:100-1000)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Has anti-apoptotic activity, Inhibits the chaperone activity of HSP70/HSC70 by promoting substrate release
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation EmissionN/A
Properties Avidin and Streptavidin bind to the small biotin and are couple to HRP or AP for ELISA, Biotin conjugates can be detected by horseradish peroxidase, To break the streptavidin Biotin bond we suggest to use a 6 molar guanidine HCl solution with acidity of pH 1, alkaline phosphatase substrates or anti biotin conjugated antibodies, 6, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetBAG3 Conjugated
Short name Conjugated, BAG3 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelBiotin
Alternative name biotinilated coupled, B-cell CLL/lymphoma 2-associated athanogene 3 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target BAG-3 and BIS and CAIR-1 and MFM6, BAG3 and IDBG-91218 and ENSG00000151929 and 9531, BT, Bag3 and IDBG-210660 and ENSMUSG00000030847 and 29810, Plasma membranes, chaperone binding, this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006457 and protein folding and biological process this GO :0007420 and brain development and biological process this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0010664 and negative regulation of striated muscle cell apoptotic process and biological process this GO :0021510 and spinal cord development and biological process this GO :0030018 and Z disc and cellular component this GO :0032403 and protein complex binding and molecular function this GO :0043005 and neuron projection and cellular component this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0050821 and protein stabilization and biological process this GO :0051087 and chaperone binding and molecular function this GO :0071260 and cellular response to mechanical stimulus and biological process this GO :0097192 and extrinsic apoptotic signaling pathway in absence of ligand and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0032403: protein complex binding and also this GO :0051087: chaperone binding, this GO :0032403: protein complex binding, this GO :0051087: chaperone binding, 65578 and IDBG-640385 and ENSBTAG00000013641 and 782633, BCL2-associated athanogene 3
Identity 939
Gene BAG3
Long gene name BCL2 associated athanogene 3
Locus 10q26, 11
Discovery year 1999-04-23
GenBank acession AF095193
Entrez gene record 9531
Pubmed identfication 9873016 18094623
RefSeq identity NM_004281
Classification BCL2 associated athanogene family
Havana BLAST/BLAT OTTHUMG00000019155
Locus Specific Databases LRG_742

Subscribe to our Newsletter